TFS Articles
Search by keyword, or choose a Focus Topic to view all articles within that area of study.
Found 195 Results
Page 1 of 22
Article
10 oncology trial readouts to watch for at ASCO 2026
Biomarker-defined populations. Rare cancers. Multi-country designs. As ASCO 2026 approaches, TFS HealthScience outlines the ten oncology trials that matter most and what they mean for sponsors planning their next programme.
Read Now
Article
From single-injection vision restoration to gene therapy: what precision ophthalmology means for trial design in 2026
Learn how ARVO 2026 signals a new era of precision ophthalmology, where smarter recruitment, imaging consistency and patient‑centric design demand deep‑tier partnerships like those offered by TFS.
Read Now
Article
News
News
Is your ClinicalTrials.gov results submission overdue?
The FDA reminded over 2,200 sponsors to submit overdue ClinicalTrials.gov results. This how TFS Medical Writing team can help.
Read Now
Article
The Value of Cross-Functional Expertise in Complex Oncology Clinical Trials
Experienced Oncology CROs with cross-functional expertise strengthen complex oncology clinical trials and accelerates clinical development.
Read Now
Article
Top 5 Challenges in Psoriasis Clinical Trials (and How to Overcome Them)
Psoriasis clinical trials face predictable hurdles, from patient recruitment shortfalls to regulatory complexity. This blog explores the five most common challenges and practical strategies sponsors can use to overcome them.
Read Now
Article
From Strategy to Patients: Adaptability and Innovation in Trial Design
Explore how adaptability, innovation, and patient focus can help sponsors rethink trial execution, from smarter sourcing models to the role of AI in oncology.
Read Now
Article
Navigating Today’s Clinical Trials: Strategies for Sponsors Facing a Shifting Landscape
Explore how sponsors can stay ahead of evolving regulatory demands, tech shifts, and enrollment pressures in today’s complex clinical trial landscape.
Read Now
Article
Rare Neurological Disease Trials: Smarter Design with Natural History, External Controls, and Real-World Evidence
Discover how natural history data, external controls, and RWE are reshaping rare neurological disease trials for smarter, regulatory-ready design.
Read Now
Article
ICH E6(R3) Is Here. Is Your Trial Ready?
Discover how TFS is helping sponsors prepare for ICH E6(R3) with proactive oversight, modern technologies, and quality-first trial design.
Read Now